key: cord-0961819-y19thuim authors: Akhtar, Naseem; Rajan, Shiv; Chakrabarti, Deep; Kumar, Vijay; Gupta, Sameer; Misra, Sanjeev; Chaturvedi, Arun; Azhar, Tashbihul; Parveen, Shirin; Qayoom, Sumaira; Niranjan, Palavalasa; Tiwari, Shashwat title: Continuing cancer surgery through the first six months of the COVID‐19 pandemic at an academic university hospital in India: A lower‐middle‐income country experience date: 2021-02-10 journal: J Surg Oncol DOI: 10.1002/jso.26419 sha: 2a3db295620c323a99879c4819df50a4d4da6a50 doc_id: 961819 cord_uid: y19thuim BACKGROUND: The novel coronavirus pandemic (COVID‐19) hinders the treatment of non‐COVID illnesses like cancer, which may be pronounced in lower‐middle‐income countries. METHODS: This retrospective cohort study audited the performance of a tertiary care surgical oncology department at an academic hospital in India during the first six months of the pandemic. Difficulties faced by patients, COVID‐19‐related incidents (preventable cases of hospital transmission), and modifications in practice were recorded. RESULTS: From April to September 2020, outpatient consultations, inpatient admissions, and chemotherapy unit functioning reduced by 62%, 58%, and 56%, respectively, compared to the same period the previous year. Major surgeries dropped by 31% with a decrease across all sites, but an increase in head and neck cancers (p = .012, absolute difference 8%, 95% confidence interval [CI]: 1.75% — 14.12%). Postoperative complications were similar (p = .593, 95% CI: −2.61% — 4.87%). Inability to keep a surgical appointment was primarily due to apprehension of infection (52%) or arranging finances (49%). Two COVID‐19‐related incidents resulted in infecting 27 persons. Fifteen instances of possible COVID‐19‐related mishaps were averted. CONCLUSIONS: We observed a decrease in the operations of the department without any adverse impact in postoperative outcomes. While challenging, treating cancer adequately during COVID‐19 can be accomplished by adequate screening and testing, and religiously following the prevention guidelines. The novel coronavirus disease pandemic has precipitated the world into an unprecedented global crisis. 1, 2 Healthcare systems all over the world have nearly collapsed in providing the necessary care for this vast burden of sick patients. As a consequence, emergency and elective care of non-COVID patients have been drastically impacted. Logistics have been adversely affected, with an ensuing diversion of resources causing severe roadblocks in managing other major health issues like cancer. Surgery is one of the cornerstones of oncological management. However, for a disease that primarily involves the lung parenchyma with consequent inflammation (Figure 1 ) leading to nearly every sixth patient developing acute respiratory distress syndrome, pulmonary function is adversely impacted leading to a further hindrance in performing surgery. 3, 4 As a large tertiary care teaching institute, our centre has been shouldering, along with others, the responsibilities of managing COVID-19 in India's most populous state catering to a populace of 200 million. Nationwide and state lockdowns which were initiated in the later part of March 2020 prevented patients from reaching the hospital. For patients with cancer, where appropriate and timely surgery is vital for achieving good outcomes, this is likely to have serious repercussions. It is quintessential to continue care of the cancer patients even during a pandemic. Nevertheless, this care must not compromise the safety of patients and healthcare professionals. We have walked through these turbulent times with utmost safety and care. Time has taught us several lessons, and we have continuously modified our approach to minimise the recurrence of such adverse events. This paper describes our experience during the first 6 months of the COVID-19 pandemic, including the functioning of our department, clinical outcomes, the problems faced by the patients, and the lessons learnt during this period. This retrospective cohort study was conducted at the Department of Surgical Oncology at an academic university hospital in north India. Being one of the oldest surgical oncology departments in India, we considered it our responsibility and continued cancer care during this pandemic. We have a prospectively maintained structured database of patients presenting in the department for receiving treatment. In this study, we included all patients that received any form of treatment at the Department of Surgical Oncology in the last 6 months, during the COVID-19 pandemic (April to September 2020) including outpatient visits, inpatient admissions, chemotherapy, and major and minor surgical procedures. Only patients with a histopathology or cytopathology proven malignancy were included. All procedures were carried out per the principles laid out in the Declaration of Helsinki, following the international guidelines for Good Clinical Practice. The institutional ethics committee allowed a waiver of formal approval in light of the retrospective nature of the study and the ongoing pandemic situation. Details of outpatient attendance, teleconsultations, total inpatient admissions, major and minor surgical procedures were recorded. Mortality, morbidity, and COVID-19 infection in patients were recorded. We compared this data with six months of our F I G U R E 1 Acute inflammation and the novel coronavirus disease [Color figure can be viewed at wileyonlinelibrary.com] pre-COVID-19 average clinical work from the same period of last year (April to September 2019). We also audited the COVID-19 related incidents in these six months (including preventable cases of hospital transmission and avoided mishaps), their causes, the effect on the functioning of the department and how they have modified our current practice. Data was collected from patients about their difficulties faced routinely at the outpatient department (OPD) or on admission. Descriptive statistics were used to describe the data. Categorical variables were compared using the χ 2 test for proportions. All tests were two-sided with a significance level set at a p value of .05. Differences in proportions were reported as applicable, along with 95% confidence intervals (CI). The data were analysed with IBM SPSS Statistics software version 24 for Linux (IBM Inc.) and R software (https://www.r-project.org). Data were compiled and analysed during October and November 2020. Our hospital is the largest tertiary care academic university centre in the most populous state of India, and it was at the forefront of managing the pandemic. The hospital was sectioned into COVID and non-COVID zones. All patients seeking elective treatment at the OPD of the hospital were required to take an online appointment from a government portal (https://ors.gov.in/index.html). Patients presenting to the emergency room were initially screened at triage, and then tested and kept at a holding area, and then referred to the respective departments for treatment, or to a dedicated COVID unit depending on their COVID-19 status. The dedicated COVID unit of the university was initially started at the main campus, but later relocated to a larger standalone facility about 500 m from the main campus realising the need for additional surge spaces and to keep the infectious facility away from the centre of the hospital. It had isolation facilities, intensive care units, emergency operation theatre services, and separate facilities for paediatric, obstetric, and surgical patients. The facility was manned by teams of healthcare workers that were on round-the-clock emergency duties, rotated by two weekly shifts from various departments of the university. The university also maintains a dedicated information portal on its website (http://www.kgmu.org/covid-19.php). Healthcare workers were instructed to follow the meticulous practices of hand hygiene, wearing masks, following social distancing norms, and avoiding group meals. Educational activities were performed via internet-based applications. From 24th July 2020, every healthcare worker had to submit daily self-declaration regarding exposure and COVID-19 like symptoms. N95 masks and face shields were used in the OPDs and operating theatres, and three-ply surgical masks elsewhere. Except for some shortages in personal protective equipment in the initial weeks of the pandemic, PPE was adequately available for rational use during surgeries. Usually, healthcare workers were tested for COVID-19 in the event of suspected contact with a COVID-19positive patient or in case of symptoms. During September 2020 when the number of cases among healthcare workers in the university was rising, the entire university was screened and tested for the virus. The underlying philosophy was to decrease crowding in OPD. Initially, we used to see all patients reporting to the surgical oncology OPD without any limit (about 200-250 patients in a day). This could potentially lead to a violation of social distancing norms and forced us to limit our OPD to 50 patients in a day, as per the institutional recommendations. Follow-up times were extended. All the patients were screened by a validated checklist (Table 1 ) developed by the department before the consultation. Patients were kept at a distance of a minimum of 2 metres. All doctors and other healthcare workers used appropriate protective gear in the OPD. Teleconsultation facilities were offered. This was based on international guidelines, and reinforced by institutional recommendations. [5] [6] [7] [8] The primary strategy was to decrease inpatient admissions (inpatient department) and the elective surgical load. To achieve this, neoadjuvant treatment options were explored as appropriate in consultation with other departments by a multidisciplinary team approach (especially for borderline inoperable patients, locally advanced patients etc.) and surgery was deferred in patients with stable disease who could be maintained on chemotherapy, metronomic or otherwise. 9 Preoperative multidisciplinary tumour board meetings were held on web-based applications. In the initial days of the pandemic when the number of cases in India was less than 1500 cases overall (23rd March to 19th April 2020), we were screening patients by a checklist only (Table 1) , which included history and temperature recording. Patients who gave a response of yes to any question, or had a fever on temperature recording were referred to an in-hospital fever clinic for evaluation. After the COVID-19 cases increased beyond 1500 but before established community transmission (20th April to 3rd July 2020), we routinely started to test patients for COVID-19 as part of preoperative workup. 10 From July 2020, with increasing concerns of AKHTAR ET AL. All healthcare workers took full precaution wearing at least three-ply surgical mask at all times. Combined ward rounds were done with minimum personnel possible. We tried to discharge patients at the earliest. Patients were informed of the availability of teleconsultation in case of any emergency. Routinely, patients were seen on follow-up after four weeks with a mandatory COVID-19 RT-PCR report. T A B L E 1 COVID-19 standard operating protocol Personal protection Following steps shall be taken by ALL employees in the department Meticulous practice of hand hygiene including washing with soap and water (for at least 20 seconds using the standard six steps) and use of 70% alcohol-based hand sanitizers. All employees to wear masks at work. Surgical masks (disposable, 3-ply) or washable double-layered cotton cloth masks shall be used. Use N-95 masks in case of aerosol-generating procedures. Social distancing Physical distancing, preferably of 2 metres shall be practiced. No prophylactic medical treatment is planned as there is an absence of strong guidelines. Self -declaration Exposure and COVID-19 symptoms (From 24th July 2020) Patients will be triaged at all levels of care with a checklist for COVID-19 combining history and body temperature measurement (thermal scanning/ digital thermometer). The underlying philosophy shall be to decrease crowding in OPD, decrease admissions and decrease the elective surgical load. To achieve this follow-up times would be extended, neo-adjuvant treatment options would be explored if feasible (especially for borderline inoperable patients, locally advanced patients) and surgery would be deferred in patients with stable disease. Following the initial triage patients will receive chemotherapy. Short courses/therapy times/oral drugs shall be preferred. Triage would be reviewed and repeated using the checklist. Patients in Surgical Oncology Ward would be allotted beds with adequate distancing (one to two vacant beds between patients). Patients being considered for surgery would be rigorously checked for the absence of COVID-19 symptomology. Mandatory RT-PCR COVID testing for patients before admission (Started from 15th June, 2020). Mandatory testing for attendants accompanying patients from (Started from 4th July, 2020). Operation Theatre Additional diligence in asepsis, inter-personal protection (especially for anaesthesiologists and the surgical team) would be undertaken at all points of time. RT-PCR COVID-19 testing before surgery (Started from 20th April, 2020). No surgery or anticancer therapy is contemplated in nonemergency situations. The standard operating protocol followed has been briefly described in Table 1 . There is a dedicated radiotherapy department in the university that The most common difficulties encountered by patients attending OPD were lack of transportation (58%), apprehension of COVID-19 infection (52%), and financial issues (36%), or logistic issues (17%) ( Table 4) . Nearly 400 patients who had been kept in the waiting list for surgery in the department did not turn up. During these six months, we encountered two COVID-19 related incidents in our department ( Table 5 ). The first happened on the 4th All the faculty members of the department were exposed as secondary contacts leading to the closure of operative services again for a week (Table 5 ). Taking cues from the previous two COVID-19 incidents, we were able to prevent at least 15 events between the period of July to September. Fifteen patients who were either planned for surgery (11) or chemotherapy (4), or their relatives were found to be COVID-19 positive. In three patients who were planned for surgery, the accompanying relatives tested positive for COVID-19. We were able to identify them because of our policy of admission only after checking a recent COVID-19 RT-PCR test report (<1 week) of the patient, and one attendant and again verifying it on the government portal for COVID-19. 12 Patients that became positive were sent to the dedicated COVID-19 unit of the university and underwent the required isolation and treatment. For patients whose relatives (contacts) were found to be positive underwent retesting after 7 days. | 1183 saw only 38% of our usual OPD load. Our total admission and chemotherapy dropped by more than 50%, and major and minor surgical procedures dropped by about 31% and 45%, respectively. Several tertiary level academic oncology centres from India have reported their experiences of cancer surgery during the pandemic. [13] [14] [15] [16] [17] [18] [19] India's largest oncology centre was reported to have a decrease in operated cases by a third. 20 Shrikhande et al. 13 Since the problem of COVID-19 seems unlikely to be resolving soon, the effect on cancer patients who could not reach hospitals in time or where surgery was not possible is a problem which cannot be addressed promptly. The consequences of delaying surgery will be detrimental for the patients and will result in the deterioration of their quality of life. A significant proportion of these cancer patients may not be amenable to curative surgery in the future due to disease progression. Hence, a contingency plan needs to be in place. 33 Lack of social support 0 (0) 71 (18) on follow up and can avoid long-distance travel. It also helps in screening individual patients who are candidates for surgical intervention. After the first incident, we modified our practice, and in addition to RT-PCR testing of the patient before admission, we also mandated testing of an accompanying attendant. We rely only on a recent RT-PCR report (<1 week). We have also restricted the number of attendants allowed with patients in the ward. We have started doing routine RT-PCR testing of all patients who were due either for chemotherapy or some minor procedures. We verify all reports from the government portal site. A limitation of accepting RT-PCR report for up to 1 week is that the patient can become positive during those seven days. However, patients were admitted in the ward with adequate distancing, counselled about hand hygiene and personal protection, and were prevented to leave the wards post-admission to reduce this probability. After the second incident, we started the policy of filling selfdeclaration form from all healthcare workers daily to confirm that they are neither exposed nor have any flu-like symptom. Replacement of injectable drugs or antibiotics with their oral counterparts was done as far as possible further to avoid close contact between staff nurses and patients. All the patients were asked to wear a mask at all times, self-temperature monitoring, minimal interpatient interaction, and counselled for frequent hand washing and proper sanitisation. The incidents which occurred in our department were avoidable. They were mainly due to human errors. One was due to incorrect manual stamping of the report, and second, was due to delayed self-reporting of symptoms. These mishaps which occurred in our department taught us a lesson that the present scenario is somewhat like fighting in a warzone; one may have bombardment from the outside (e.g., the first accident in our department) or from the inside, like a clandestine cell system or sleeper cells (e.g., the second accident in our ward). 38 It is thus essential to safeguard oneself by proper screening, testing, verification of reports and promotion of teleconsultation. It is even more critical to prevent oneself from becoming this sleeper cell by following strict preventive personal and social guidelines (like social distancing, wearing proper protective gear religiously and avoid gatherings) and prompt self-reporting of exposure or symptoms related to COVID-19. Although there may be a need to ration personal protective equipment on occasions, it should not leave healthcare workers exposed. 39 In addition to managing and treating COVID-19 patients on a priority basis, there is an often unmet need to treat non-COVID-19 patients simultaneously so that their morbidity and mortality can be decreased to a reasonable limit. To this end, segregation of hospitals into COVID and non-COVID zones, ramping up testing of non- Patient-3 Hospital staff-0 All (10) resident doctors primarily exposed All consultants secondarily exposed Department closed operative services for 1 week (1) We have started checking RT-PCR COVID- 19 reports on portal site 12 (2) Checking COVID-19 RT-PCR of the patient and one attendant before admitting any patient (3) Divided resident doctors in two teams to prevent all residents to be infected at a time. (One to look after OPD and preoperative ward and second to look after OT and postoperative ward) 19th August, 2020 Ward sister Ignoring mild sore throat Patient-3 Hospital staff-18 including staff of preoperative, postoperative ward and OT Residents-3 All consultants, resident doctors, and staff primarily exposed Department closed operative services for 1 week (1) Filling self-declaration form for hospital staff and doctors Explaining the importance of self-declaration about wellness (2) If any symptoms or exposure of COVID-19, immediate quarantine, and joining after negative RT-PCR AKHTAR ET AL. and there can be a no bigger misfortune than infecting patients during treatment. Thus, rigorous screening and testing of the patients, promoting teleconsultations, following the prevention guidelines, prompt self-declaration of exposure or symptom by healthcare workers is key to success in this battle. The principles of "lead well, choose well, cut well, stay well" are more applicable now than ever. 40 Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study The Eleventh Hour Low-dose radiotherapy for SARS-CoV-2 pneumonia Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study COVID-19: Guidance for Triage of Non-Emergent Surgical Procedures n Strategies for perioperative management of general surgery in the post-COVID-19 era: experiences and recommendations from frontline surgeons in Wuhan Mandatory preoperative COVID-19 testing for cancer patients-Is it justified? Perioperative cancer care in the context of limited resources during the COVID-19 Pandemic: Brazilian Society of Surgical Oncology Recommendations Metronomic chemotherapy for scheduling oral cancer surgery during the COVID-19 pandemic Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic Revised Guidelines for TrueNat testing for COVID-19 2020 Outcomes of elective major cancer surgery during COVID 19 at Tata Memorial Centre: implications for Cancer Care Policy Impact of the initial phase of COVID-19 pandemic on surgical oncology services at a tertiary care center in Eastern India Outcomes of cancer surgery during the COVID-19 pandemic: preparedness to practising continuous cancer care Managing cancer during COVID pandemic-experience of a tertiary cancer care center Continuing surgical care in cancer patients during the nationwide lockdown in the COVID-19 pandemic-perioperative outcomes from a tertiary care cancer center in India Cancer care in a Western Indian tertiary center during the pandemic: Surgeon's perspective Cancer management in India during Covid-19 Flattening the curve in oncologic surgery: impact of Covid-19 on surgery at tertiary care cancer center Cancer guidelines during the COVID-19 pandemic Elective surgery in the time of COVID-19 Recommandations de la Société française de chirurgie oncologique (SFCO) pour l'organisation de la chirurgie oncologique durant l'épidémie de COVID-19 Protecting surgical teams during the COVID-19 outbreak COVID-19 and the General Surgical Department-measures to reduce spread of SARS-COV-2 among surgeons Recommendations for general surgery activities in a pandemic scenario (SARS-CoV-2) Global guidance for surgical care during the COVID-19 pandemic Surgery during the COVID-19 pandemic: operating room suggestions from an international Delphi process Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans A novel and simple technique of reconstructing the central arch mandibular defects-a solution during the resource-constrained setting of COVID crisis Preparedness of the cancer hospitals and changes in oncosurgical practices during COVID-19 pandemic in India: A cross-sectional study Are we harming cancer patients by delaying their cancer surgery during the COVID-19 pandemic? Immediate and long-term impact of the COVID-19 pandemic on delivery of surgical services Global Observatory for eHealth series Teleoncology: the youngest pillar of oncology Telemedicine for cancer care in the time of COVID-19 re stepping on my cloak and dagger Personal protective equipment (PPE) for surgeons during COVID-19 pandemic: a systematic review of availability, usage, and rationing Elective surgery after the pandemic: waves beyond the horizon The authors wish to thank all the residents, staff, and patients of the department without whose cooperation this work would not be possible. The authors also wish to thank Dr. Ankita Ray, postdoctoral researcher at UC Louvain, Belgium (formerly of ETH Zürich, Swit- The authors declare that there are no conflict of interests. Relevant datasets for this manuscript are available from the corresponding author on reasonable request.